BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12490527)

  • 1. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein.
    Jiang H; Nucifora FC; Ross CA; DeFranco DB
    Hum Mol Genet; 2003 Jan; 12(1):1-12. PubMed ID: 12490527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis.
    Sugars KL; Brown R; Cook LJ; Swartz J; Rubinsztein DC
    J Biol Chem; 2004 Feb; 279(6):4988-99. PubMed ID: 14627700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
    Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
    Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
    Bates EA; Victor M; Jones AK; Shi Y; Hart AC
    J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
    Wetzel R
    Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues.
    Chiang MC; Lee YC; Huang CL; Chern Y
    J Biol Chem; 2005 Apr; 280(14):14331-40. PubMed ID: 15689617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. scyllo-Inositol promotes robust mutant Huntingtin protein degradation.
    Lai AY; Lan CP; Hasan S; Brown ME; McLaurin J
    J Biol Chem; 2014 Feb; 289(6):3666-76. PubMed ID: 24352657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.
    Poirier MA; Jiang H; Ross CA
    Hum Mol Genet; 2005 Mar; 14(6):765-74. PubMed ID: 15689354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins.
    Ko J; Ou S; Patterson PH
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):319-29. PubMed ID: 11719267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).
    Prigge JR; Schmidt EE
    BMC Mol Biol; 2007 Sep; 8():76. PubMed ID: 17868456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-interacting motifs inhibit aggregation of polyQ-expanded huntingtin.
    Miller SLH; Scappini EL; O'Bryan J
    J Biol Chem; 2007 Mar; 282(13):10096-10103. PubMed ID: 17276991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-interacting protein pathway: degradation of an ubiquitin-binding protein.
    Shimizu M; Oguro-Ando A; Ohoto-Fujita E; Atomi Y
    Methods Enzymol; 2014; 534():323-30. PubMed ID: 24359962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity.
    Khoshnan A; Ko J; Patterson PH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):1002-7. PubMed ID: 11792860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway.
    Cong SY; Pepers BA; Zhou TT; Kerkdijk H; Roos RA; van Ommen GJ; Dorsman JC
    Neurobiol Dis; 2012 Jun; 46(3):673-81. PubMed ID: 22426400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.
    Li X; Wang CE; Huang S; Xu X; Li XJ; Li H; Li S
    Hum Mol Genet; 2010 Jun; 19(12):2445-55. PubMed ID: 20354076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
    J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
    Banerjee M; Datta M; Bhattacharyya NP
    Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.
    Scappini E; Koh TW; Martin NP; O'Bryan JP
    Hum Mol Genet; 2007 Aug; 16(15):1862-71. PubMed ID: 17550941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.
    Zhang X; Abels ER; Redzic JS; Margulis J; Finkbeiner S; Breakefield XO
    Cell Mol Neurobiol; 2016 Apr; 36(3):459-70. PubMed ID: 26951563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.